Oz & Roizen: Supplements to avoid when taking SSRI drugs for depression

I’m taking the serotonin-reuptake inhibitor sertraline (Zoloft) for depression. I feel so much better, and I assumed it was OK to keep taking my vitamins. But are there supplements I should watch out for? — Cecilia H., Ossining, New York

Congrats on taking charge of your depression and feeling better. Yes, there are certain supplements that interfere with selective serotonin-reuptake inhibitors (SSRIs), and with serotonin and noradrenalin reuptake inhibitors (SNRIs) too.

Serotonin is a neurotransmitter found in your gut, your blood and your nervous system. It’s considered a natural mood stabilizer. You probably weren’t getting the right balance, and the sertraline has helped you re-establish that! Since we don’t know your exact dosage or the supplements you are taking, we can’t directly answer your question. You should talk to your doctor about all the supplements and herbal preparations you may be using. When you do, here are some specifics to discuss:

• Ask your doctor about the risks of taking St. John’s wort, garcinia cambogia, L-tryptophan (or 5-HTP) and SAMe (S-adenosyl-methionine) supplements with your antidepressant. Consumer Labs says they can increase your risk of experiencing serotonin syndrome. That’s when there’s an overabundance of serotonin in your system that triggers everything from goosebumps and shivering to muscle rigidity, diarrhea and heavy sweating. (If that happens, do not ever abruptly stop taking your SSRI or SNRI!)

• Also ask about the potential benefits of these supplements: A study in the American Journal of Psychiatry found that omega-3 fish oil (specifically EPA) in combo with SSRIs caused a significant reduction in depressive symptoms. It was also true to a lesser extent for vitamin D and methylfolate, a form of folic acid.

I was on a plane, and the person next to me was watching one of the latest action movies. I won’t single it out, but it was nonstop violence — and rated PG-13! How can this not negatively affect impressionable youngsters? — Jesse J., Sioux Falls, South Dakota

The Motion Picture industry has eroded standards so that the PG-13 rating (parents strongly cautioned, for children under 13) means next to nothing. The Harvard School of Public Health warned that a “ratings creep” (it’s a voluntary system) has allowed more violent and sexually explicit content into films that are seen by young teens. Recently, the American Academy of Pediatrics reported that gun violence in PG-13-rated films has more than tripled since 1985. And public health and mental health experts agree that nonstop violence in films (and on TV and in video games) can make kids more aggressive and damage their emotional development. So our advice to parents:

1. Do diligent research when your teen wants to see a movie. Find out how much and what type of violence a film contains, and check out Common Sense Media (commonsensemedia.org). In its Parents’ Guide, it gives ratings for categories such as positive messages, positive role models, sex, violence, language, drinking, drugs and smoking, and a review.

Here’s a partial review of the Cohen Brothers’ adaptation of the Western “True Grit,” which is rated PG-13. CommonSense gave it an age 15+. They say: “impressive and forceful, but it’s also full of brutal (and sometimes bloody) gunfight sequences and other violent moments that aren’t appropriate for younger viewers … mature teens are likely to feel a kinship with the lead character, 14-year-old Mattie Ross …They might even learn from her adventure … lessons … dealing with loyalty, courage and determination.”

2. Ask around and find out what other parents have to say. If you’re not sure about the content, watch the movie first or watch with your youngster.

3. Talk to your kids about violence in the media. Help them evaluate what is gratuitous and reject its message. Remember, if teens want to see a movie, with all the streaming available these days, chances are they will, even if you say no. So be proactive and help them avoid the upsetting and mind-bending violence that’s out there.

Mehmet Oz, M.D. is host of “The Dr. Oz Show,” and Mike Roizen, M.D. is Chief Wellness Officer and Chair of Wellness Institute at Cleveland Clinic.

Article source: http://www.onlineathens.com/news/20180716/oz-amp-roizen-supplements-to-avoid-when-taking-ssri-drugs-for-depression

Quarterly Updates | Q2 2018

To keep everyone aware of big projects and efforts across WordPress contributor teams, I’ve reached out to each team’s listed representatives. I asked each of them to share their Top Priority (and when they hope for it to be completed), as well as their biggest Wins and Worries. Have questions? I’ve included a link to each team’s site in the headings.

Accessibility

  • Contacted: @rianrietveld, @joedolson, @afercia
  • Priority: Working to make sure that Gutenberg is reasonably accessible prior to merge. ETA is before 5.0
  • Struggle: Lack of developers and accessibility experts to help test and code the milestone issues. The team is doing outreach to help solve this problem.
  • Big Win: Interest from companies like The Paciello Group and Tenon.io to help out with Gutenberg code review and testing tools.

CLI

  • Contacted: @danielbachhuber, @schlessera
  • Priority: Very first global Hack Day is coming up July 20. Version 2.0.0 is still in progress (new ETA is end of July).
  • Struggle: The team continues to need new contributors. The current team is tiny but tough.
  • Big Win: WP-CLI is currently one of the project’s four main focuses, as mentioned in the Summer Update at WordCamp Europe.

Community

  • Contacted: @francina, @hlashbrooke
  • Priority: Focusing on smoothing out the processes in our community management by building up our team of volunteers and establishing what tools we need to keep things running well. ETA is ongoing.
  • Struggle: Our two biggest struggles at the moment are tracking what we need to get done, and making final decisions on things. There is current work on the tools available to assist with tracking progress.
  • Big Win: After making a concerted effort to get more contributors on the Community Team, we now have a much larger group of volunteers working as deputies and WordCamp mentors

Core

  • Contacted: @jeffpaul
  • Priority: Following the WordCamp Europe summer update (and the companion post here), the team is getting Gutenberg (the new WordPress editing experience) into a strong state for the 5.0 release. Potential ETA as soon as August.
  • Struggle: Coordinating momentum and direction as we start seeing more contributors offering their time. Still working our way through open issues. The team is starting multiple bug scrubs each week to work through these more quickly and transparently.
  • Big Win: Had a sizable release in 4.9.6 which featured major updates around privacy tools and functionality in Core.

Design

  • Contacted: @melchoyce, @karmatosed, @boemedia, @joshuawold, @mizejewski
  • Priority: Better on-boarding of new contributors, especially creating better documentation. ETA is end of July.
  • Struggle: It’s hard to identify reasonably small tasks for first-time contributors.
  • Big Win: The team is much more organized now which has helped clear out the design backlog, bring in new contributors, and also keep current contributors coming back. Bonus: Joshua Wold will co-lead the upcoming release.

Documentation

  • Contacted: @kenshino
  • Priority: Opening up the work on HelpHub to new contributors and easing the onboarding process. No ETA.
  • Struggle: Some blockers with making sure the code and database can be ready to launch on https://wordpress.org/support/
  • Big Win: The first phase of HelpHub creation is complete, which means content updates (current info, more readable, easier discovery), internal search, design improvements, and REST API endpoints.

Hosting

  • Contacted: @mikeschroder, @jadonn
  • Priority: Preparing hosts for supporting Gutenberg, especially support questions they’re likely to see when the “Try Gutenberg” callout is released. ETA July 31st, then before WordPress 5.0
  • Struggle: Most contributions are still made a by a small team of volunteers. Seeing a few more people join, but progress is slow.
  • Big Win: New team members and hosting companies have joined the #hosting-community team and have started contributing.

Marketing

  • Contacted: @bridgetwillard
  • Priority: Continuing to write and publish case studies from the community. ETA is ongoing.
  • Struggle: No current team struggles.
  • Big Win: Wrote and designed a short Contributor Day onboarding card. It was used at Contributor Day at WCEU and onboarding time went down to 1 hour instead of 3 hours.

Meta (WordPress.org Site)

  • Contacted: @tellyworth, @coffee2code
  • Priority: Reducing manual work around the contributor space (theme review, GDPR/privacy, plugin review). ETA for small wins is end of quarter, larger efforts after that.
  • Struggle: Maintaining momentum on tickets. There are also some discussions about updating the ticket management process across teams that use the Meta trac system.
  • Big Win: The new About page launched and has been translated across most locale sites.

Mobile

  • Contacted: @elibud
  • Priority: Getting Gutenberg in the mobile applications. ETA is late December.
  • Struggle: Consuming the Gutenberg source in the ReactNative app directly. More info can be found here: https://make.wordpress.org/mobile/2018/07/09/next-steps-for-gutenberg-mobile/
  • Big Win: The WordPress mobile applications now fully support right-to-left languages and are compliant with the latest standards for accessibility.

Plugins

  • Contacted: @ipstenu
  • Priority: Clearing ~8,000 unused plugins from the queues. Likely ETA is September.
  • Struggles: Had to triage a lot of false claims around plugins offering GDPR compliance.
  • Big Win: Released 4.9.6 and updated expectations with plugin authors. Huge thanks to the Core Privacy team for their hard work on this.

Polyglots

  • Contacted: @petya, @ocean90, @nao, @chantalc, @deconf, @casiepa
  • Priority: Keep WordPress releases translated to 100% and then concentrate on the top 100 plugins and themes. ETA is ongoing.
  • Struggle: Getting new PTEs fast enough, and complex tools/systems. Overall, the volume of strings awaiting approval.

Support

  • Contacted: @clorith
  • Priority: Getting ready for the Gutenberg callout (it got pushed last quarter). Needing a better presence on the official support forums, and outreach for that is underway, ETA end of July. 
  • Struggle: Keeping contributors participating post-contributor days/drives. Considering the creation of a dedicated post-contributor day survey to get some insight here.
  • Big Win: The increase in international liaisons joining for weekly meetings, helping bring the wider support community together.

Theme Review

Tide

  • Contacted: @valendesigns (but usually @jeffpaul)
  • Priority: Storing PHPCompatibilty results inside the WordPress.org API and building a UI to display those results, an endpoint to request an audit is required for this work to continue.
  • Struggle: Development has dramatically slowed down while team members are on leave or pulled into internal client work.
  • Big Win: Migration to Google Cloud Platform (GCP) from Amazon Web Services (AWS) is complete and the audit servers have all been rewritten in Go. (This allows us to be faster with greater capacity and less cost.)

Training

  • Contacted: @bethsoderberg, @juliek
  • Priority: Lesson plan production. ETA is ongoing.
  • Struggle: The workflow is a little complex, so recruiting and training enough contributors to keep the process moving is a struggle.
  • Big Win: WordCamp Europe’s Contributor Day was very productive. New tools/workflow are in place and two team representatives were there to lead and help.

Interested in updates from the first quarter of this year? You can find those here: https://make.wordpress.org/updates/2018/04/24/quarterly-updates-q1-2018/

Regentatlantic Capital Has Trimmed United Therapeutics Del (UTHR) Holding By $423024; NUTRAFUELS (NTFU …

<!–

Market News

–>

July 15, 2018 – By Mary Kidd

United Therapeutics Corporation (NASDAQ:UTHR) Logo

NUTRAFUELS INC (OTCMKTS:NTFU) had a decrease of 37.5% in short interest. NTFU’s SI was 2,500 shares in July as released by FINRA. Its down 37.5% from 4,000 shares previously. The SI to NUTRAFUELS INC’s float is 0.01%. The stock increased 5.00% or $0.01 during the last trading session, reaching $0.21. About 19,490 shares traded. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since July 15, 2017 and is . It has underperformed by 12.57% the SP500.

Regentatlantic Capital Llc decreased United Therapeutics Corp Del (UTHR) stake by 30.94% reported in 2018Q1 SEC filing. Regentatlantic Capital Llc sold 3,777 shares as United Therapeutics Corp Del (UTHR)’s stock declined 10.66%. The Regentatlantic Capital Llc holds 8,432 shares with $947,000 value, down from 12,209 last quarter. United Therapeutics Corp Del now has $5.43B valuation. The stock increased 0.48% or $0.6 during the last trading session, reaching $124.74. About 125,357 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 12.46% since July 15, 2017 and is downtrending. It has underperformed by 25.03% the SP500. Some Historical UTHR News: 02/05/2018 – Analytic Investors LLC Exits Position in United Therapeutics; 02/05/2018 – United Therapeutics 1Q Adj EPS $3.76; 02/05/2018 – UNITED THERAPEUTICS 1Q ADJ. EPS 3.76, EST. $3.56; 30/04/2018 – United Therapeutics: Milestone Related to Commercialization of Trevyent; 26/03/2018 Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem’s Strategic Advisory Board; 30/04/2018 – UNITED THERAPEUTICS: DEAL VALUED AT $216M; 30/04/2018 – United Therapeutics to Buy SteadyMed — Deal Digest; 30/04/2018 – United Therapeutics to Buy SteadyMed for $4.46/Share Cash at Closing; 30/04/2018 – United Therapeutics To Acquire SteadyMed Ltd. STDY; 02/05/2018 – United Therapeutics 1Q Net $244.5M

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $17.92 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

Since March 14, 2018, it had 0 insider buys, and 12 selling transactions for $27.22 million activity. ROTHBLATT MARTINE A had sold 21,512 shares worth $2.42 million. Olian Judy D. had sold 600 shares worth $67,425. Another trade for 3,240 shares valued at $366,353 was sold by DWEK RAYMOND.

Among 3 analysts covering United Therapeutics (NASDAQ:UTHR), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. United Therapeutics had 9 analyst reports since January 19, 2018 according to SRatingsIntel. The stock of United Therapeutics Corporation (NASDAQ:UTHR) has “Underperform” rating given on Thursday, February 22 by Credit Suisse. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned “Neutral” rating by Credit Suisse on Tuesday, April 3. Credit Suisse maintained the shares of UTHR in report on Thursday, May 3 with “Neutral” rating. The firm has “Underweight” rating by Barclays Capital given on Thursday, May 3. The stock has “Buy” rating by Wedbush on Friday, May 4. The firm earned “Neutral” rating on Tuesday, July 10 by Credit Suisse. Barclays Capital maintained the stock with “Underweight” rating in Thursday, February 22 report. As per Tuesday, February 27, the company rating was maintained by Wedbush.

Another recent and important United Therapeutics Corporation (NASDAQ:UTHR) news was published by Globenewswire.com which published an article titled: “Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics …” on June 25, 2018.

Analysts await United Therapeutics Corporation (NASDAQ:UTHR) to report earnings on July, 26. They expect $2.57 earnings per share, up 305.60% or $3.82 from last year’s $-1.25 per share. UTHR’s profit will be $111.91M for 12.13 P/E if the $2.57 EPS becomes a reality. After $5.57 actual earnings per share reported by United Therapeutics Corporation for the previous quarter, Wall Street now forecasts -53.86% negative EPS growth.

Regentatlantic Capital Llc increased Jpmorgan Chase Co (AMJ) stake by 82,677 shares to 1.45M valued at $34.89 million in 2018Q1. It also upped Dxc Technology Co stake by 42,754 shares and now owns 94,047 shares. Vanguard Index Fds (VOO) was raised too.

Investors sentiment decreased to 0.87 in Q1 2018. Its down 0.27, from 1.14 in 2017Q4. It fall, as 33 investors sold UTHR shares while 124 reduced holdings. 41 funds opened positions while 96 raised stakes. 40.96 million shares or 0.16% more from 40.90 million shares in 2017Q4 were reported. Advisory Svcs Network Lc accumulated 100 shares. Archford Cap Strategies Limited Liability Corp has 6 shares. Old Bancshares In holds 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 3,434 shares. Strategic Advsrs Ltd Llc has 0.38% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 9,990 shares. Pictet Asset Management holds 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 111,139 shares. Wellington Grp Inc Llp reported 9,375 shares stake. Moreover, Korea Invest Corp has 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 64,056 shares. South Dakota Investment Council reported 0.13% stake. Brown Advisory, Maryland-based fund reported 3,000 shares. Retirement Of Alabama invested in 0.03% or 55,923 shares. Apg Asset Mgmt Nv has 0.12% invested in United Therapeutics Corporation (NASDAQ:UTHR). Caisse De Depot Et Placement Du Quebec has 0% invested in United Therapeutics Corporation (NASDAQ:UTHR). Convergence Investment Prtnrs holds 0% or 149 shares in its portfolio. California State Teachers Retirement System stated it has 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Liberty Mutual Group Asset Mgmt invested 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR).

United Therapeutics Corporation (NASDAQ:UTHR) Institutional Positions Chart

Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Article source: https://cardinalweekly.com/regentatlantic-capital-has-trimmed-united-therapeutics-del-uthr-holding-by-423024-nutrafuels-ntfu-sellers-decreased-by-37-5-their-shorts/

Amy Schumer Takes Down Diet Fads in This Exclusive ‘I Feel Pretty’ Deleted Scene

Amy Schumer is not about that diet life in this exclusive deleted scene from the I Feel Pretty Blu-ray, which is available starting Tuesday, July 17.

After suffering a bump on the head, Renée (Schumer) gains a new perspective on her body and begins to live her life free from the bonds of body-image issues. When she sits down for a meal with her work friends and notices that they’re both trying to control their weight using some questionable diet fads, she gives them some advice based on her years of experience.

“Let me guess, eight-day juice cleanse,” she says as one friend sips a green concoction and nods. “I’ve been there. And then every night they give you that sweet little almond milk and it’s supposed to be like a treat at the end of the day, but it really just feels like an eff you.”

@BritandCo!

(photo via Mark Schafer/Motion Picture Artwork)

Article source: https://www.brit.co/exclusive-deleted-scene-i-feel-pretty/

Weight Loss Dietary Supplements Market is Anticipated to be Valued at US$ 37177.6 Million by 2026

As per the latest study by Persistence Market Research (PMR), the global weight loss dietary supplements market is anticipated to witness healthy growth. The market is likely to register 6.0% CAGR throughout the forecast period 2017-2026. The global weight loss dietary supplements market is also estimated to bring in US$ 37,177.6 million revenue by 2026 end.

With obesity becoming a global health concern, weight loss continues to be one of the most focused areas. Hence, increasing number of companies are coming up with the new products in weight loss supplements. The increasing consumption and demand for weight loss dietary supplements, regulations on the production of these supplements along with ingredients used are also gaining traction in various countries. The government in various countries are also focusing on the quality and quantity of ingredients used and if any of these ingredients can have severe side-effects, affecting the health of the consumers negatively.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/20380 

Increasing use of Natural and Organic Ingredients in the Weight Loss Dietary Supplements

The negative effects of being obese and overweight are resulting in the increasing use of weight management products. Consumers are also adopting weight loss supplements in forms of pill, liquid, and powder. Hence, with the increase in the use of these supplements, manufacturers are also trying to produce safer products, thereby using organic and natural ingredients and plant-based ingredients. Among various ingredients, green tea extract is considered as one of the most popular and safest ingredients in the weight loss dietary supplements. Similarly, Garcinia cambogia is also being considered as an ingredient in the weight loss supplements. However, these ingredients have been reported to have adverse effects like a headache, constipation, UTI. Hence, there has been an increase in the investment in the research on other organic ingredients that can be used to produce weight loss supplements.

Global Weight Loss Dietary Supplements Market: Segmental Insights

The global weight loss dietary supplements market includes various segments such as end-user, form, ingredients, distribution channel, and region. Based on the form, the market is categorized into powder, liquid, and soft gell/pills. Soft gell/pills are expected to dominate the market during the forecast period. By the end of 2026, soft gell/pills are expected to exceed US$ 18,500 million revenue.

Based on the end-user, the segment consists of men, women and senior citizen. Among these, women are expected to be the largest users of weight loss dietary supplements. Women segment as the end-user is estimated to create an incremental opportunity of more than US$ 7,900 million between 2017 and 2026.

By Distribution Channel, pharmacies drug store is expected to emerge as the largest distribution channel for the weight loss dietary supplements. Pharmacies drug store is estimated to account for more than one-third of the revenue share by the end of 2017.

Based on the ingredients, the segment consists of amino acids, vitamins minerals, botanical supplements, and others. Vitamins minerals are expected to emerge as one of the largest used ingredients in the weight loss dietary supplements. By the end of 2026, vitamins minerals are estimated to exceed US$ 16,900 million revenue.

Region-wise, the market is categorized into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). Among the given regions, North America is expected to dominate the global weight loss dietary supplements market throughout the forecast period 2017-2026.

Access Report with Table of Contents @ https://www.persistencemarketresearch.com/methodology/20380 

Global Weight Loss Dietary Supplements Market: Competitive Assessment

Key players in the global weight loss dietary supplements market are Amway (Nutrilite), Abott Laboratories, GlaxoSmithKline, Glanbia, Herbalife International, Pfizer, American Health, Stepan, Nature’s Sunshine Products, and FANCL.

Article source: https://thestockanalysis.com/weight-loss-dietary-supplements-market-is-anticipated-to-be-valued-at-us-37177-6-million-by-2026/

Powered by Gewgley